LEVY; Odile Esther

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEVY; Odile Esther.The latest application filed is for "engineered polypeptides having enhanced duration of action with reduced immunogenicity".

Company Profile

0.31.38

LEVY; Odile Esther - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Engineered Polypeptides Having Enhanced Duration Of Action With Reduced Immunogenicity App 20180344813 - ERICKSON; Mary ; et al.	2018-12-06
Hybrid polypeptides with selectable properties Grant 9,453,063 - Levy , et al. September 27, 2	2016-09-27
GIP analog and hybrid polypeptides with selectable properties Grant 9,133,260 - Levy , et al. September 15, 2	2015-09-15
Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same App 20150231204 - LEVY; Odile Esther ; et al.	2015-08-20
Peptide-peptidase Inhibitor Conjugates And Methods Of Using Same App 20140371148 - GHOSH; Soumitra S. ; et al.	2014-12-18
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same Grant 8,906,849 - Levy , et al. December 9, 2	2014-12-09
GIP and exendin hybrid polypeptides Grant 8,895,498 - Levy , et al. November 25, 2	2014-11-25
Hybrid Polypeptides With Selectable Properties App 20140249299 - Levy; Odile Esther ; et al.	2014-09-04
Amylin-calcitonin Chimeric Peptides Conjugated To Duration Enhancing Moieties App 20140249076 - Samant; Manoj P. ; et al.	2014-09-04
Peptide-peptidase inhibitor conjugates and methods of using same Grant 8,759,295 - Ghosh , et al. June 24, 2	2014-06-24
Hybrid polypeptides with selectable properties Grant 8,697,647 - Levy , et al. April 15, 2	2014-04-15
Polypeptide Conjugate App 20140066370 - Forood; Behrouz Bruce ; et al.	2014-03-06
Pancreatic polypeptide family motifs and polypeptides comprising the same Grant 8,603,969 - Levy , et al. December 10, 2	2013-12-10
Peptide-peptidase-inhibitor conjugates and methods of making and using same Grant 8,598,314 - Ghosh , et al. December 3, 2	2013-12-03
Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same App 20130303442 - LEVY; Odile Esther ; et al.	2013-11-14
Dpp-iv Resistant Gip Hybrid Polypeptides With Selectable Properties App 20130281374 - Levy; Odile Esther ; et al.	2013-10-24
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20130196913 - Levy; Odile Esther ; et al.	2013-08-01
DPP-IV resistant GIP hybrid polypeptides with selectable properties Grant 8,497,240 - Levy , et al. July 30, 2	2013-07-30
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20130137631 - LEVY; Odile Esther ; et al.	2013-05-30
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same Grant 8,426,361 - Levy , et al. April 23, 2	2013-04-23
GIP analog and hybrid polypeptides with selectable properties Grant 8,404,637 - Levy , et al. March 26, 2	2013-03-26
Hybrid Polypeptides With Selectable Properties App 20120253023 - LEVY; Odile Esther ; et al.	2012-10-04
GIP analog and hybrid polypeptides with selectable properties Grant 8,263,545 - Levy , et al. September 11, 2	2012-09-11
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant RE43,298 - Saksena , et al. April 3, 2	2012-04-03
Hybrid polypeptides having glucose lowering activity Grant 8,076,288 - Levy , et al. December 13, 2	2011-12-13
DPP-IV Resistant GIP Hybrid Polypeptides with Selectable Properties App 20110136737 - Levy; Odile Esther ; et al.	2011-06-09
Novel Peptides As Ns3-serine Protease Inhibitors Of Hepatitis C Virus App 20110117057 - Saksena; Anil K. ; et al.	2011-05-19
Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same App 20100292172 - GHOSH; SOUMITRA S. ; et al.	2010-11-18
Peptide-peptidase-inhibitor Conjugates And Methods Of Making And Using Same App 20100286365 - Ghosh; Soumitra S. ; et al.	2010-11-11
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same Grant 7,723,471 - Levy , et al. May 25, 2	2010-05-25
Pancreatic Polypeptide Family Motifs, Polypeptides And Methods Comprising The Same App 20100099619 - Levy; Odile Esther ; et al.	2010-04-22
Hybrid Polypeptides with Selectable Properties App 20090286723 - Levy; Odile Esther ; et al.	2009-11-19
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,595,299 - Saksena , et al. September 29, 2	2009-09-29
Peptide-peptidase Inhibitor Conjugates And Methods Of Using Same App 20090186817 - Ghosh; Soumitra S. ; et al.	2009-07-23
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20090036364 - Levy; Odile Esther ; et al.	2009-02-05
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20080312157 - Levy; Odile Esther ; et al.	2008-12-18
Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation Grant 7,262,211 - Tamiz , et al. August 28, 2	2007-08-28
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,244,721 - Saksena , et al. July 17, 2	2007-07-17
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20070032433 - Saksena; Anil K. ; et al.	2007-02-08
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,169,760 - Saksena , et al. January 30, 2	2007-01-30
Hybrid polypeptides with selectable properties App 20060293232 - Levy; Odile Esther ; et al.	2006-12-28
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20060205672 - Saksena; Anil K. ; et al.	2006-09-14
Pancreatic polypeptide family motifs, polypeptides and methods comprising the same App 20060135747 - Levy; Odile Esther ; et al.	2006-06-22
Hybrid polypeptides with selectable properties App 20060094652 - Levy; Odile Esther ; et al.	2006-05-04
Pancreatic polypeptide family motifs and polypeptides comprising the same App 20060094653 - Levy; Odile Esther ; et al.	2006-05-04
Matriptase inhibitors and methods of use Grant 7,019,019 - Duncan , et al. March 28, 2	2006-03-28
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,012,066 - Saksena , et al. March 14, 2	2006-03-14
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20050176648 - Saksena, Anil K. ; et al.	2005-08-11
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20050059606 - Saksena, Anil K. ; et al.	2005-03-17
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20040254117 - Saksena, Anil K. ; et al.	2004-12-16
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 6,800,434 - Saksena , et al. October 5, 2	2004-10-05
Matriptase inhibitors and methods of use App 20040186060 - Duncan, David F. ; et al.	2004-09-23
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20030216325 - Saksena, Anil K. ; et al.	2003-11-20
Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation App 20030207842 - Tamiz, Amir P. ; et al.	2003-11-06
Non-covalent inhibitors of urokinase and blood vessel formation Grant 6,586,405 - Semple , et al. July 1, 2	2003-07-01
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20030036501 - Saksena, Anil K. ; et al.	2003-02-20
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20020160962 - Saksena, Anil K. ; et al.	2002-10-31
Non-covalent inhibitors of urokinase and blood vessel formation App 20020037857 - Semple, Joseph Edward ; et al.	2002-03-28